MedTrace Logo

Comparison of Modified With Conventional Adaptive Servoventilation Processes

NCT01037439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-02-05

No results posted yet for this study

Summary

The objective of this study is to compare the modified adaptive servoventilation control algorithm of the with the standardised algorithms of routinely-used servoventilation processes (AutoSet CS2) in terms of the effect on obstructive and central events. The aim is to normalise breathing during sleep and hence eliminate the sleep-related breathing disorder, resulting in even more effective treatment of nocturnal breathing disorders in patients with cardiovascular diseases and sleep apnoea, to ensure optimum therapy success.

Conditions

  • Periodic Breathing
  • Cheyne-Stokes Respiration

Interventions

DEVICE

Adaptive Servo-controlled Ventilation (ASV)

Pressure support ventilation adapts to meet a target ventilation level that is constantly being assessed

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Helmut Teschler, MD · University Hospital, Ruhrland Hospital Essen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-09-30
Completion
2009-12-31

Countries

  • Germany

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01037439 on ClinicalTrials.gov